Benzonatate Dosage Recommendations
For adults and children over 10 years of age, the recommended dose of benzonatate is one 100 mg or 200 mg capsule three times a day as needed for cough, with a maximum daily dose of 600 mg divided into three doses. 1
Dosing Guidelines
- Standard dosing: 100-200 mg three times daily
- Maximum daily dose: 600 mg (divided into three doses)
- Administration: Capsules must be swallowed whole, never chewed, crushed, dissolved, or broken 1
- Age restriction: Contraindicated in children under 10 years of age due to risk of accidental ingestion and death 2
Clinical Considerations
Patient Selection
- Benzonatate is typically used as a fourth-line therapy in cough management after:
- First-line: Demulcents
- Second-line: Opiate derivatives
- Third-line: Peripherally acting antitussives 2
Special Populations
- Children: Only approved for ages 10 years and older
- Elderly patients: Standard adult dosing applies, though patients with cardiovascular or renal comorbidities may be safer using menthol-based products 2
Duration of Treatment
- If symptoms do not improve after a short course of treatment, discontinue benzonatate and try another approach 2
Efficacy and Safety
Benzonatate has shown efficacy in controlling cough, particularly in challenging cases:
- Effective for cancer-related cough unresponsive to opioids 3, 4
- Shows efficacy in acute viral cough, especially when combined with guaifenesin 5
Safety Warnings
- Serious risks: Cardiac arrest has been reported with overdose 6
- Administration: Patient education about proper dosing and administration is critical to avoid serious adverse effects 2
- Mechanism: As a local anesthetic structurally similar to tetracaine and procaine, benzonatate works peripherally by anesthetizing stretch receptors in the lungs 3
Clinical Application
When prescribing benzonatate:
- Start with 100 mg three times daily for most patients
- Increase to 200 mg three times daily if needed for adequate cough control
- Monitor response within the first few days of treatment
- Discontinue if no improvement is observed after a short trial
- Emphasize to patients that capsules must be swallowed whole
Benzonatate remains one of the few non-opioid antitussives with demonstrated efficacy in both acute and chronic cough settings, making it a valuable option when other treatments have failed.